CytoDyn Inc (CYDY)
0.155
0.00 (0.00%)
USD |
OTCM |
Apr 19, 15:59
CytoDyn 1 Year Total Returns (Daily): -49.14% for April 18, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 18, 2024 | -49.14% |
April 17, 2024 | -52.37% |
April 16, 2024 | -50.99% |
April 15, 2024 | -51.99% |
April 12, 2024 | -43.93% |
April 11, 2024 | -48.87% |
April 10, 2024 | -51.80% |
April 09, 2024 | -53.38% |
April 08, 2024 | -50.88% |
April 05, 2024 | -52.56% |
April 04, 2024 | -55.60% |
April 03, 2024 | -56.34% |
April 02, 2024 | -56.54% |
April 01, 2024 | -54.32% |
March 28, 2024 | -56.47% |
March 27, 2024 | -55.69% |
March 26, 2024 | -52.31% |
March 25, 2024 | -51.45% |
March 22, 2024 | -51.51% |
March 21, 2024 | -50.40% |
March 20, 2024 | -52.85% |
March 19, 2024 | -53.80% |
March 18, 2024 | -54.62% |
March 15, 2024 | -55.36% |
March 14, 2024 | -55.92% |
Date | Value |
---|---|
March 13, 2024 | -53.68% |
March 12, 2024 | -57.06% |
March 11, 2024 | -54.65% |
March 08, 2024 | -55.33% |
March 07, 2024 | -50.17% |
March 06, 2024 | -41.67% |
March 05, 2024 | -36.78% |
March 04, 2024 | -21.01% |
March 01, 2024 | -32.48% |
February 29, 2024 | -19.77% |
February 28, 2024 | -50.06% |
February 27, 2024 | -51.08% |
February 26, 2024 | -48.58% |
February 23, 2024 | -49.20% |
February 22, 2024 | -50.86% |
February 21, 2024 | -48.48% |
February 20, 2024 | -44.86% |
February 16, 2024 | -41.42% |
February 15, 2024 | -39.26% |
February 14, 2024 | -35.43% |
February 13, 2024 | -39.29% |
February 12, 2024 | -35.51% |
February 09, 2024 | -35.51% |
February 08, 2024 | -39.70% |
February 07, 2024 | -42.03% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.79%
Minimum
Apr 20 2022
1.79K%
Maximum
Jun 29 2020
104.6%
Average
-37.92%
Median
1 Year Total Returns (Daily) Benchmarks
NovaBay Pharmaceuticals Inc | -95.06% |
Palatin Technologies Inc | -28.68% |
iBio Inc | -91.81% |
Theriva Biologics Inc | -39.12% |
Oragenics Inc | -65.23% |